Pharma Times

JUNE 15, 2023

EO2463 is an experimental treatment for indolent non-Hodgkin B cell lymphoma - News - PharmaTimes

107

107

Commonwealth Pharmacists Association

AUGUST 8, 2022

CPA raising the profile of pharmacy at CHOGM 2022 The theme for CHOGM 2022 was ‘Delivering a Common Future: Connecting, Innovating, Transforming.’ In the first of a series of 2 blogs, Mr Flandrie Habyarimana reports on his experiences and attendance at CHOGM, representing the CPA and pharmacists across the Commonwealth.

52

52

Pharmacy Times

JUNE 2, 2023

Findings presented at the American Society of Clinical Oncology (ASCO) 2023 meeting show the long-term efficacy and safety profile of larotrectinib (Vitrakvi; Bayer) in solid tumors with NTRK gene fusion.

49

49

Pharma Times

SEPTEMBER 5, 2022

Study involving children aged six to 11 years with moderate-to-severe asthma reveals positive data

121

121

STAT

APRIL 16, 2024

Dry mouth, fatigue, and tremor were the most commonly reported side effects, and the drug’s overall tolerability profile was consistent with previous studies, the company said. The drug also showed a significant benefit on a patient-reported measure of depression symptom severity. Continue to STAT+ to read the full story…

Drug Development 310

Drug Development 310

STAT

APRIL 2, 2024

The experimental medicine has garnered attention for its potential to show incretin-like weight loss with muscle preservation, and a tolerable side-effect profile. Danish drugmaker Zealand Pharma — yes, there’s another Danish drug maker in obesity — is developing a long-acting amylin analog called petrelintide.

285

285

STAT

DECEMBER 6, 2023

After multiple other high-profile trials failed , a PrEPVacc investigator described the study this summer as “ the last roll of the dice ” for an HIV vaccine until the 2030s.  The trial, known as PrEPVacc, was testing two different vaccine regimens on about 1,500 volunteers in East and Southern Africa.

Vaccines 363

Vaccines Drug Development 363

STAT

FEBRUARY 2, 2024

Two high-profile abortion supporters filed a petition in January requesting the board define what would be grounds for a legal abortion, and their efforts are backed by activists from across the political divide.

363

363

STAT

APRIL 10, 2024

” Shipley’s last day as chief advocacy officer at BIO was Friday, and his profile has been removed from the group’s website. The departure was sudden, and he immediately packed up his office and left the building, according to three sources familiar with the departure.

338

338

Outsourcing Pharma

OCTOBER 20, 2023

Matteo Lai was part of a panel at DPharm in Boston this year, it was called working together to accelerate the adoption of digital biomarkers in clinical trials.

83

83

Express Pharma

JUNE 23, 2023

The post EU approval boosts Bimzelx’s profile as innovative interleukin-17 inhibitor therapy: GlobalData appeared first on Express Pharma.

52

52

Pharmacy Times

APRIL 5, 2024

These FDA-approved therapies are used to treat lymphoma after 2 or more lines of therapy and represent significant advancements in the treatment of lymphoma.

49

49

PharmExec

SEPTEMBER 11, 2023

Pharm Exec’s latest selections of notable biopharma brand launches—some with novel preemptive approaches—highlight products that are paving uncharted paths across a diverse disease landscape.

59

59

STAT

FEBRUARY 28, 2024

Elisabeth Bik, a microbiologist by training, has become one of the world’s most influential science detectives.

361

361

Pharmaceutical Technology

DECEMBER 19, 2023

Super pollutants like black carbon found their way onto the agenda of COP28, which hosted the annual conference's first 'Health Day'

52

52

Pharmacy Times

AUGUST 22, 2023

Zydus Pharmaceuticals (USA) Inc, has come a long way since its first commercial launch in August 2005.

49

49

Drug Channels

FEBRUARY 14, 2023

This Valentine's Day, what could be more romantic than a deep dive into the relationships between manufacturers of specialty drugs and the pharmacies they choose for their limited and exclusive specialty pharmacy networks.

Specialty Pharmacies 74

Specialty Pharmacies 74

pharmaphorum

MAY 17, 2021

The plans to float on the London Stock Exchange’s Alternative Investment Market (AIM) will raise the company’s profile, widen shareholder base and improve the chances of finding and expanding commercial partnerships. The post Arecor hopes London stock market float will raise profile of insulin products appeared first on.

Diabetes 52

Diabetes Biosimilars Hospitals Vaccines 52

STAT

APRIL 14, 2023

WASHINGTON — Even though the Biden administration is ending its highest-profile Covid-19 emergency declaration next month, it’s still going to hold on to some pandemic-era powers.

Vaccines 356

Vaccines 356

Pharmacy Times

OCTOBER 27, 2023

Adverse event profiles of several approved CDK4/6 inhibitors are discussed.

26

26

STAT

FEBRUARY 8, 2024

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies.

Hospitals 284

Hospitals 284

Pharma Times

OCTOBER 25, 2021

Product designed to allow laboratories to expand in-house oncology research

99

99

pharmaphorum

DECEMBER 10, 2020

The post OVID Health appoints high-profile leaders as senior counsel appeared first on. In the past year the agency has achieved six-figure growth and launched the Patient Partnership Index , an initiative that aims to help create better partnerships between the pharma industry and patient communities.

Communication 52

Communication Immunity Immunization Vaccines 52

STAT

DECEMBER 12, 2023

Meanwhile, don’t miss Allison DeAngelis’s fascinating profile on Reed Jobs and his investment in oncology. For me, that means I am flying home to Italy (with Tuna — please send any and all tips for long flights with spicy little dogs) at the end of this week. Read the rest…

Drug Pricing 243

Drug Pricing Drug Development 243

Pharmaceutical Technology

MAY 19, 2023

The US Supreme Court has unanimously voted in favour of Sanofi and Regeneron in a years-long legal feud with Amgen over the potential patent infringement surrounding the companies’ anti-cholesterol drugs. This marks a milestone in the dispute nearly a decade after the first lawsuit filed by Amgen against the two companies.

59

59

STAT

SEPTEMBER 14, 2023

John Green, a novelist and high-profile YouTuber, is once again leveraging his star power in the global fight to end tuberculosis. His latest target? The diagnostics company Cepheid and the price of its tuberculosis test, GeneXpert. Cepheid sells individual test cartridges for $9.98

363

363

STAT

SEPTEMBER 28, 2023

But some participants had data profiles that didn’t match their pregnancy stage — and it was those pregnancies, the researchers found, that were more likely to result in a preterm birth. No surprise: Their sleep typically got worse and their activity slowed down over the course of pregnancy. Read the rest…

329

329

Pharmacy Times

APRIL 15, 2024

Bristol Myers Squibb will also present findings on apixaban (Eliquis) at the American College of Cardiology Annual Scientific Session and Expo.

26

26

Pharmaceutical Technology

AUGUST 8, 2023

Wegovy has been approved in the US and Europe for weight loss management in patients aged 12 years and older.

52

52

Pharmacy Times

MAY 15, 2023

Investigators of the phase 2 study also found a comparable reactogenicity to the individual influenza and COVID-19 vaccines from Novavax or authorized vaccine comparators.

Vaccines 55

Vaccines 55

PharmExec

SEPTEMBER 9, 2022

Spotlighting the stories of five noteworthy biopharma brand launches—and the diverse disorders they address with novel approaches in science and market access.

52

52

PharmaVoice

DECEMBER 6, 2022

The company’s head of R&D on its profile-raising FDA approval of a gene therapy that’s now the world’s most expensive drug.

246

246

STAT

JUNE 21, 2023

Last year, after a string of high-profile trial failures , the Huntington’s disease community got positive news in the form of very early data from an experimental gene therapy for the rare neurodegenerative condition.

Drug Development 345

Drug Development 345

STAT

JANUARY 25, 2024

Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

278

278

STAT

FEBRUARY 13, 2024

Ultimately, this medicine was shown to have a better side effect profile than TDF. It had also done preliminary work on a similar but different drug — tenofovir alafenamide fumarate (TAF) — for which it had early, although not definitive, evidence for safety and efficacy.

Drug Development 310

Drug Development 310

STAT

DECEMBER 1, 2022

Amgen released detailed data on Thursday suggesting an early-stage drug can induce significant weight loss in patients with obesity, with less frequent dosing than current treatments but a safety profile that remains unclear.

272

272

STAT

OCTOBER 18, 2023

A high-profile Wall Street Journal article recently highlighted what everyone knows: There is huge need but no market demand. The antibiotics crisis is a silent pandemic that threatens to knock modern society back into the medieval age of therapeutic leaches and serum therapy. A world where an accidental scratch in the rose garden can kill.

Hospitals 290

Hospitals 290